We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
ARAB HEALTH - INFORMA

Download Mobile App




Shellfish Exoskeletons May Reduce Radiation Poisoning

By HospiMedica staff writers
Posted on 03 Oct 2006
An investigator is currently is investigating a novel approach based on a readily available biomaterial that could potentially be used to reduce an individual's radiation dose.

At present, there are no effective methods to isolate and remove radionuclides from humans in the event of a detonation of a suitcase-sized nuclear bomb by a terrorist in a major city. More...
Dr. Tatiana Levitskaia, a scientist from Pacific Northwest National Laboratory (Richmond, WA, USA), reported on the technology at the U.S. national meeting of the American Chemical Society, held in September 2006 in San Francisco (CA, USA).

Chitosan is a natural and safe compound that has been found to be an effective chelator for a wide range of nuclides. Chitosan is obtained from chitin and found in the exoskeletons of many invertebrates such as crabs and prawns. It is one of the most abundant, readily available, and renewable natural biopolymers, second only to cellulose.

Some chitosan materials can be chemically engineered to improve their affinity to specific radionuclides. By binding to radionuclides, scientists hypothesize that chitosan may inhibit deposition in bones and vital organs such as the liver and kidney, and speed up removal from the body.

Dr. Levitskaia's investigation is targeted at finding a natural chelator such as chitosan that can safely and effectively rid the body of diverse radionuclides such as actinides, cobalt, strontium, and radium. Currently, Dr. Levitskaia's research involves the removal of cobalt from living tissues in laboratory rats. Results are expected in the fall of 2006.



Related Links:
Pacific Northwest National Laboratory

Gold Member
12-Channel ECG
CM1200B
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Semi‑Automatic Defibrillator
Heart Save AED (ED300)
Bipolar Coagulation Generator
Aesculap
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Surgical Techniques

view channel
Image: The new probe is just three times the width of the diameter of a single hair (Photo courtesy of John A. Rogers/Northwestern University)

First-Of-Its-Kind Probe Monitors Fetal Health in Utero During Surgery

Fetal surgery is performed to treat life-threatening conditions before birth, but monitoring a fetus during these procedures remains extremely limited. Clinicians currently rely on intermittent ultrasound... Read more

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image:The biotechnology market in the GCC is projected to reach $2.6 billion by 2028, with the UAE and Saudi Arabia leading the growth in the region (Photo Courtesy of Infroma Markets)

WHX in Dubai (formerly Arab Health) to debut specialised Biotech & Life Sciences Zone as sector growth accelerates globally

World Health Expo (WHX) in Dubai, formerly Arab Health, which takes place from 9-12 February 2026 at the Dubai Exhibition Centre (DEC), has officially announced the launch of a new dedicated Biotech &... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.